1Segal BH, Herbreeht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria. Clin Infect Dis, 2008, 47 : 674-683. 被引量：1
2Saag MS, Graybill R J, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis, 2000, 30:710-718. 被引量：1
3Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trail. Lancet, 2004, 363 : 1764-1767. 被引量：1
4Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients : a randomized trial. Clin Infect Dis, 2008, 47 : 123-130. 被引量：1
5Van Der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical TriMs Group. N Engl J Med, 1997, 337:15-21. 被引量：1
6Dromer Bernede-Bauduin F, C, Guillemot D, et al. Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS One, 2008, 3 :e2870-2879. 被引量：1
7Bennett JE, Dismukes WE, Duma RV, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal menin~tis. N Engl J Med, 1979, 301 : 126-131. 被引量：1
8Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med, 1987, 317:334-341. 被引量：1
9Pappas P, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis, 2001, 33:690-699. 被引量：1
10Pasqualotto AC. Amphotericin B: the higher the dose, the higher the toxicity. Clin Infect Dis, 2008, 47: 1110. 被引量：1
4Bartlett KH, Cheng PY ,Duncan C,et al.A decade of experience: Cryptococcus gattii in British Columbia [ J ]. Mycopathologia, 2012,173(5-6) :311-319. 被引量：1
5Lortholary O, Polzat G, ZeUer V, et 81. Long-term outcome of AIDS-asseciated cryptococcosis in the era of combination antiret- roviral therapy[ J].AIDS,2006,20(17) :2183-2191. 被引量：1
6Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier[ J]. Tmncls Neurosci,2001,24(12) :719-725. 被引量：1
7Pukkila-Worley R, Mylonakis E.Epidemiology and management of cryptococcal meningitis:developments and challenges[ J ] .Ex- pert Opin Pharmacother,2008,9(4) :551-560. 被引量：1
8Y Benjamini YH.ControUing the false discovery rate:a practical and powerful approach to multiple testing.1995. 被引量：1
9A Alexa JR. topGO : enrichment analysis for gene ontology. R package version2010. 被引量：1
10Rozycka M,Lu YJ,Brown RA,.cDNA cloning of a third human C2-domain-containing class II phosphoinositide 3-kinase, PI3K- C2gamma, and chromosomal assignment of this gene (PIK3C2G) to 12p12E Jl .C, enomics, 1998,54(3) :569-574. 被引量：1
